Here's what is coming soon to NeurologyLive.
Every week, the NeurologyLive staff prepares this preview of what to expect from our coverage. This week on NeurologyLive, there are a number of hot topics that we will be posting throughout the week. As always, our weekly coverage extends beyond just these topics, so make sure to check out the rest of the site!
Don't miss your chance to register for this week's free webinar, part of our series the Ever-Changing Face of Multiple Sclerosis, put on in partnership with the Consortium of Multiple Sclerosis Centers. It airs on Wednesday, May 19, at 7PM ET. You'll join Ahmed Obeidat, MD, PhD; Mitch Freedman, MD; and Suma Shah, MD, for the second program of this monthly series as they discuss the evolution of therapeutics for the treatment of multiple sclerosis. To register for this program for free, click here.
To view the enduring version of the first program, click here.
Throughout the week, the NeurologyLive Peers & Perspectives series, "Dystrophin and Its Role in Effective Treatment of Duchenne Muscular Dystrophy (DMD)," will air new episodes! This series features Vamshi K. Rao, MD, and Eric P. Hoffman, PhD, who discuss all things related to the care of patients with DMD. Thus far, the pair has given a review of the condition overall and the mutations involved with it as well as discussed micro-dystrophin, its place in gene therapy developments, and relevance in the clinical setting in relation to DMD.
To catch up on the series, click here.
Also on Wednesday, be sure to check out the MJH Life Sciences Medical World News channel, as a number of new shows featuring your peers and colleagues in medicine will air! This week, NeurologyLive will appear on the "Second Opinion." The episode will feature Eric Segal MD, and Jurriaan Peters, MD, who discuss the recently published EPISTOP trial in tuberous sclerosis complex, including a debate about its strengths and weaknesses, its potential implications for clinical practice, and how they approach patient management for this rare epilepsy.
To check out what's on the Medical World News channel now, click here.
The latest in our NeuroVoices series, dedicated to conversations with leaders in the neurology community, also goes live on Wednesday, May 19. This week, it features Stephanie J. Nahas, MD, associate professor, and director, Headache Medicine Fellowship Program, Thomas Jefferson University, who discusses her research on optimizing treatment regimens for patients with migraine. Nahas provides insight on how clinicians can better tailor their treatment regimens, where the issues of poor treatment optimization stem from, and ways to raise overall awareness for those who may be eligible for migraine treatments but have not yet received care.
To check out the prior NeuroVoices conversations, click here.
Throughout the week, the NeurologyLive Peers & Perspectives series, "The Patient-Centered Visit & Shared Decision Making in the Management of Migraine," will air additional episodes. The series features Jill Dehlin, RN, a patient advocate and migraineur, Amaal J. Starling, MD, a migraine specialist at Mayo Clinic, who offer their insights into the existing stigmas associated with the disease, strategies to empower patients with migraine, advocacy resources, and the importance of quality of life measures in the patient population, among other topics of discussion.
To catch up on the series, click here.
On Friday, May 21, episode 37 of the NeurologyLive "Mind Moments" podcast will go live. This time, the show will feature a conversation with Matthew B. Harms, MD, associate professor of neurology, Columbia University, and medical consultant and care center director, Muscular Dystrophy Association, in honor of ALS Awareness Month. Harms will discuss the impact that awareness efforts have had on the clinical development in ALS, and offer an update on the current landscape of care.
To subscribe on your favorite podcast player, click here.
As a reminder, the April 2021 print issue of NeurologyLive is now available on our website. Some of the feature pieces included are "Magnetic Resonance’s Impact on Diagnosis, Prognostication, and Therapeutic Approaches in Neuromuscular Disorders," by Kenneth Bender, PharmD, MA; "A Critical Evaluation of Disease-Modifying Strategies in Parkinson Disease," by Fernando L. Pagan, MD, Charbel Moussa, MBBS, PhD, and Yasar Torres-Yaghi, MD; and "Neurosurgery and Parkinson Disease: Past, Present, and Future of Deep Brain Stimulation," by Atom Sarkar, MD, PhD, among others.
To view the issue in digital form, click here.